Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Reexamination Certificate
2011-08-09
2011-08-09
Powers, Fiona T (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
C534S752000, C534S798000
Reexamination Certificate
active
07994156
ABSTRACT:
This invention relates to novel carboxylic acid 4-phenylazo-phenyl ester derivatives useful as monoamine neurotransmitter re-uptake inhibitors.In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
REFERENCES:
patent: 7662808 (2010-02-01), Peters et al.
patent: 7687523 (2010-03-01), Peters et al.
patent: 7750011 (2010-07-01), Peters et al.
patent: 2008/0146582 (2008-06-01), Peters et al.
patent: 2009/0075983 (2009-03-01), Peters et al.
patent: 2010/0234384 (2010-09-01), Peters et al.
patent: WO 2007/093600 (2007-08-01), None
patent: WO 2007/135120 (2007-11-01), None
patent: WO 2007/135122 (2007-11-01), None
Cuckle, Howard S., “Primary Prevention of Down's syndrome”, International Journal of Medical Sciences, 2005.
Nielsen βlsebet Østergaard
Peters Dan
Redrobe John Paul
Birch & Stewart Kolasch & Birch, LLP
NeuroSearch A/S
Powers Fiona T
LandOfFree
Carboxylic acid 4-phenylazo-phenyl ester derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxylic acid 4-phenylazo-phenyl ester derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxylic acid 4-phenylazo-phenyl ester derivatives and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2781904